Selank Research Guide
5mg · Research compound — not for human consumption
Research Overview
Selank is a synthetic heptapeptide analog of the endogenous immunopeptide tuftsin. It has been studied in preclinical and laboratory settings for its interactions with neurochemical and immunomodulatory pathways. This is a research compound not intended for human consumption.
Structural & Class Overview
Synthetic heptapeptide; a stabilized analog of the immunopeptide tuftsin (Thr-Lys-Pro-Arg) extended with a Pro-Gly-Pro sequence for metabolic stability. Mechanistically studied as a modulator of multiple systems (GABAergic, serotonergic, and BDNF-associated signaling) rather than a single-receptor agent.
General Research Interest
Research interest includes modulation of GABAergic signaling in laboratory models; effects on BDNF expression in hippocampal and prefrontal cortex tissue; interactions with serotonergic pathways; preclinical models of anxiety-related behavior; and study of tuftsin-derived immunomodulatory activity.
Storage Considerations
General handling for a lyophilized research peptide: store lyophilized powder frozen and protected from light and moisture; once reconstituted, keep refrigerated and minimize freeze-thaw cycles. For laboratory research use only.
Testing & Quality Considerations
Quality considerations include HPLC purity assessment, mass spectrometry for identity/molecular weight confirmation, and review of a batch-specific Certificate of Analysis (COA) to verify purity and identity.
References
- Selank Attenuates Aversive Signs of Morphine Withdrawal in Rats (PubMed)
- Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Rats (PMC)
References are provided for scientific context. Linked sources are independent and not affiliated with iNGEN MD.
